# RECARBRIO

NDC: 0006-3856
Generic name: imipenem anhydrous, cilastatin, and relebactam anhydrous
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200106

FDA application: NDA212819

## Active ingredients

- CILASTATIN: 500 mg/100mL
- IMIPENEM ANHYDROUS: 500 mg/100mL
- RELEBACTAM ANHYDROUS: 250 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3856"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3856
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be32f468-738b-40df-a425-591e12f65159